Loading cancer entity…
Loading cancer entity…
Clinical trials
17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06903208 | RFA for Superficial Lipomas | recruiting | N/A | 10 | Columbia UniversityOTHER | 1 | Aug 14, 2026 | clinicaltrials |
| NCT07014163 | Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas | recruiting | N/A | 10 | Espad PharmedINDUSTRY | 1 | Jun 10, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Aug 14, 2026source: clinicaltrials